A company in the US that owns the intellectual property for a potentially new method of treating spinal cord injuries has hailed its discovery as "revolutionary".
NeuroRepair, a corporation founded by Matthew Klipstein after he suffered a neurological injury in a sports accident in 2000, said it is committed to developing a therapy based on a protein called TGF alpha.
The company cited the "startling success" of two studies carried out by scientists at the University of California that tested a neuroregenerative therapy in rats.
NeuroRepair continued: "The therapy may eventually help restore limb function in people with impaired mobility, long after they have experienced a stroke, traumatic injury or the onset of neurodegenerative disorders such as Parkinson's disease."
The company believes that the results from those studies, which were announced in an online press release on UC Irvine Today, validate its ownership of the intellectual property.
Meanwhile, scientists at the University in Kentucky have discovered that the small molecule withaferin A can combat two key proteins which are implicated in a damaging biological process associated with brain injuries.
News from Serious Law, specialist spinal injury lawyers